UNSPSC 51431707: Clentiazem maleate

This classification denotes a calcium channel blocker with the molecular formula C22H25ClN2O4S.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YN4F0N5QE0, chemically known as 1,5-benzothiazepin-4(5h)-one, 3-(acetyloxy)-8-chloro-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, (2s-cis)-, (z)-2-butenedioate (1:1) but more generally known as clentiazem maleate, which bears US NIH Compound Identifier 6435546. Most nations, for tariff and trade purposes, schedule clentiazem maleate under HS 29349990 and SITC 51579.

As of Q4 2014, CLENTIAZEM MALEATE remains US FDA's Preferred Term for this commodity. SMILES: CC(=O)O[C@@H]1[C@@H](SC2CC(CCC2N(C1=O)CCN(C)C)CL)C3CCC(CC3)OC.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51431707 Clentiazem maleate, a Commodity code, covers pharmaceutical supply and distribution to state and local health agencies, primarily emergency medical services and pharmacy benefit programs. Recent opportunities show state and local governments procuring individual medication line items and multi-source generic pharmaceuticals through both direct competitive bids and cooperative purchasing arrangements. The City of Tampa's Purchasing Department, the Texas Health and Human Services Commission, and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the issuing-body mix: municipal fire and rescue departments, state health agencies, and cooperative purchasing entities serving multiple jurisdictions. The scope includes supply of specific medication vials and injections (such as Labetalol, Epinephrine, Adenosine, and Diltiazem formulations) with firm pricing including freight and delivery to designated locations, manufacturers' compliance with cGMP and Drug Supply Chain Security Act standards, and management of expiration-dating and replacement protocols.

Recent activity spans Florida, Texas, and Minnesota with multistate reach through MMCAP. The City of Tampa issued IFB 26P00188 for Advanced Life Support Medications on April 24, 2026, with a response deadline of April 8, 2026 (closed), seeking four specific medication line items with an estimated contract value of $40,000 and Small Local Business Enterprise set-asides available; Tampa Fire Rescue is the using department. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026, with responses due March 26, 2026, to establish two-year contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers to state and local facilities across Minnesota and Oregon, with pricing weighted at 75 percent of evaluation. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling exploratory procurement before a formal RFP focused on direct contracting alternatives to traditional pharmacy benefit manager and wholesaler arrangements.